Raymond James Financial
BIIB icon

Raymond James Financial’s Biogen BIIB Stock Holding History

Raymond James Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Buy
96,699
+12,985
+16% +$2.39M 0.01% 1565
2025
Q4 		$14.7M Buy
83,714
+30,372
+57% +$4.96M ﹤0.01% 1664
2025
Q3 		$7.47M Buy
53,342
+1,345
+3% +$182K ﹤0.01% 2152
2025
Q2 		$6.53M Buy
51,997
+10,034
+24% +$1.25M ﹤0.01% 2185
2025
Q1 		$5.74M Sell
41,963
-100,005
-70% -$14.3M ﹤0.01% 2241
2024
Q4 		$21.7M Buy
+141,968
New +$23.9M 0.01% 1243

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial's BIIB Position: Q1 2026 in Review

Raymond James Financial increased its Biogen (BIIB) stake by 16% in Q1 2026, buying an estimated $2.39M and bringing the position to 96,699 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #1565.

Raymond James Financial first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. The position peaked at $21.7M in Q4 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Raymond James Financial held 96,699 shares of Biogen worth $17.7M as of Q1 2026.
  • Raymond James Financial bought 12,985 Biogen shares in Q1 2026, an estimated $2.39M.
  • Biogen made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1565 holding.
  • Raymond James Financial first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Biogen position peaked at $21.7M in Q4 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.